• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估体内突变频率,并创建丙型肝炎病毒全基因组高分辨率适应代价图谱。

Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus.

机构信息

Department of Biology, San Francisco State University, San Francisco, California, United States of America.

BC Centre for Excellence in HIV/AIDS, Vancouver, British Colombia, Canada.

出版信息

PLoS Genet. 2022 May 2;18(5):e1010179. doi: 10.1371/journal.pgen.1010179. eCollection 2022 May.

DOI:10.1371/journal.pgen.1010179
PMID:35500034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9113599/
Abstract

Like many viruses, Hepatitis C Virus (HCV) has a high mutation rate, which helps the virus adapt quickly, but mutations come with fitness costs. Fitness costs can be studied by different approaches, such as experimental or frequency-based approaches. The frequency-based approach is particularly useful to estimate in vivo fitness costs, but this approach works best with deep sequencing data from many hosts are. In this study, we applied the frequency-based approach to a large dataset of 195 patients and estimated the fitness costs of mutations at 7957 sites along the HCV genome. We used beta regression and random forest models to better understand how different factors influenced fitness costs. Our results revealed that costs of nonsynonymous mutations were three times higher than those of synonymous mutations, and mutations at nucleotides A or T had higher costs than those at C or G. Genome location had a modest effect, with lower costs for mutations in HVR1 and higher costs for mutations in Core and NS5B. Resistance mutations were, on average, costlier than other mutations. Our results show that in vivo fitness costs of mutations can be site and virus specific, reinforcing the utility of constructing in vivo fitness cost maps of viral genomes.

摘要

像许多病毒一样,丙型肝炎病毒 (HCV) 具有很高的突变率,这有助于病毒快速适应,但突变伴随着适应度代价。适应度代价可以通过不同的方法来研究,例如实验或基于频率的方法。基于频率的方法特别适用于估计体内适应度代价,但这种方法在有大量宿主的深度测序数据时效果最佳。在这项研究中,我们应用基于频率的方法对来自 195 名患者的大型数据集进行了分析,并估计了 HCV 基因组中 7957 个位点的突变适应度代价。我们使用贝塔回归和随机森林模型来更好地理解不同因素如何影响适应度代价。我们的结果表明,非同义突变的代价是同义突变的三倍,而 A 或 T 核苷酸的突变代价高于 C 或 G 核苷酸的突变代价。基因组位置有一定的影响,HVR1 中的突变代价较低,而核心和 NS5B 中的突变代价较高。耐药突变的代价通常比其他突变高。我们的结果表明,体内突变的适应度代价可能具有特定的位置和病毒特异性,这增强了构建病毒基因组体内适应度代价图谱的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/28cef60897bc/pgen.1010179.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/3094421b99a6/pgen.1010179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/be46aa42e8e2/pgen.1010179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/9fcc2b8a3210/pgen.1010179.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/c6c903dae36a/pgen.1010179.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/f09729bb530a/pgen.1010179.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/28cef60897bc/pgen.1010179.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/3094421b99a6/pgen.1010179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/be46aa42e8e2/pgen.1010179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/9fcc2b8a3210/pgen.1010179.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/c6c903dae36a/pgen.1010179.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/f09729bb530a/pgen.1010179.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba7/9113599/28cef60897bc/pgen.1010179.g006.jpg

相似文献

1
Assessing in vivo mutation frequencies and creating a high-resolution genome-wide map of fitness costs of Hepatitis C virus.评估体内突变频率,并创建丙型肝炎病毒全基因组高分辨率适应代价图谱。
PLoS Genet. 2022 May 2;18(5):e1010179. doi: 10.1371/journal.pgen.1010179. eCollection 2022 May.
2
Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.适应性突变增强了基于高滴度丙型肝炎病毒5a基因型核心-NS2 JFH1的重组体的组装及细胞间传播。
J Virol. 2015 Aug;89(15):7758-75. doi: 10.1128/JVI.00039-15. Epub 2015 May 20.
3
Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity.慢性丙型肝炎患者经利巴韦林治疗后,丙型肝炎病毒(HCV)聚合酶的突变导致耐药性,并影响病毒复制保真度。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01417-20.
4
Genome-Wide Mutagenesis of Hepatitis C Virus Reveals Ability of Genome To Overcome Detrimental Mutations.全基因组诱变的丙型肝炎病毒揭示了基因组克服有害突变的能力。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01327-19.
5
mutation rates and the landscape of fitness costs of HIV-1.HIV-1的突变率与适应性代价格局
Virus Evol. 2017 Mar 2;3(1):vex003. doi: 10.1093/ve/vex003. eCollection 2017 Jan.
6
Genomic variability of within-host hepatitis C variants in acute infection.急性感染中宿主内丙型肝炎病毒变异株的基因组变异性。
J Viral Hepat. 2019 Apr;26(4):476-484. doi: 10.1111/jvh.13051. Epub 2019 Jan 22.
7
Highly heterogeneous mutation rates in the hepatitis C virus genome.丙型肝炎病毒基因组中高度异质性的突变率。
Nat Microbiol. 2016 Apr 18;1(7):16045. doi: 10.1038/nmicrobiol.2016.45.
8
Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate.定量原发性丙型肝炎病毒(HCV)感染期间的多样性:体内突变率的估计。
PLoS Pathog. 2012;8(8):e1002881. doi: 10.1371/journal.ppat.1002881. Epub 2012 Aug 23.
9
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations.人类白细胞抗原 B27 选择罕见的逃逸突变,这些突变显著削弱丙型肝炎病毒的复制,并需要补偿性突变。
Hepatology. 2011 Oct;54(4):1157-66. doi: 10.1002/hep.24541.
10
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy.丙型肝炎病毒基因组NS5B区域的突变与α干扰素加利巴韦林联合治疗的临床结果相关。
J Gastroenterol Hepatol. 2005 Sep;20(9):1401-9. doi: 10.1111/j.1440-1746.2005.04024.x.

引用本文的文献

1
The Application of Single-Cell Technologies for Vaccine Development Against Viral Infections.单细胞技术在抗病毒感染疫苗研发中的应用
Vaccines (Basel). 2025 Jun 26;13(7):687. doi: 10.3390/vaccines13070687.
2
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals.规避传统抗病毒药物出现耐药性的策略与努力。
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
3
Evolutionary safety of lethal mutagenesis driven by antiviral treatment.抗病毒治疗驱动的致死性诱变的进化安全性。

本文引用的文献

1
SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV- Co-Infection.SIV 在食蟹猴体内共感染时的进化动力学。
Viruses. 2021 Dec 29;14(1):48. doi: 10.3390/v14010048.
2
Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a.丙型肝炎病毒 1a、1b 和 3a 宿主内突变模式和多样性的比较分析。
Viruses. 2021 Mar 19;13(3):511. doi: 10.3390/v13030511.
3
CpG-creating mutations are costly in many human viruses.在许多人类病毒中,产生CpG的突变成本高昂。
PLoS Biol. 2023 Aug 8;21(8):e3002214. doi: 10.1371/journal.pbio.3002214. eCollection 2023 Aug.
4
Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a.丙型肝炎病毒 1a、1b 和 3a 宿主内突变模式和多样性的比较分析。
Viruses. 2021 Mar 19;13(3):511. doi: 10.3390/v13030511.
Evol Ecol. 2020;34(3):339-359. doi: 10.1007/s10682-020-10039-z. Epub 2020 Apr 24.
4
Viral quasispecies.病毒准种。
PLoS Genet. 2019 Oct 17;15(10):e1008271. doi: 10.1371/journal.pgen.1008271. eCollection 2019 Oct.
5
Defective viral genomes are key drivers of the virus-host interaction.缺陷型病毒基因组是病毒-宿主相互作用的关键驱动因素。
Nat Microbiol. 2019 Jul;4(7):1075-1087. doi: 10.1038/s41564-019-0465-y. Epub 2019 Jun 3.
6
RNA Virus Fidelity Mutants: A Useful Tool for Evolutionary Biology or a Complex Challenge?RNA 病毒保真度突变体:进化生物学的有用工具还是复杂的挑战?
Viruses. 2018 Nov 1;10(11):600. doi: 10.3390/v10110600.
7
Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV.患者内突变频率揭示了 HIV 中 CpG 二核苷酸和剧烈氨基酸变化的适应代价。
PLoS Genet. 2018 Jun 28;14(6):e1007420. doi: 10.1371/journal.pgen.1007420. eCollection 2018 Jun.
8
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.丙型肝炎病毒耐药相关替代及其临床意义:2018 年更新。
Drug Resist Updat. 2018 Mar;37:17-39. doi: 10.1016/j.drup.2018.01.004. Epub 2018 Feb 21.
9
Sociovirology: Conflict, Cooperation, and Communication among Viruses.社会病毒学:病毒之间的冲突、合作与交流。
Cell Host Microbe. 2017 Oct 11;22(4):437-441. doi: 10.1016/j.chom.2017.09.012.
10
Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.了解丙型肝炎病毒耐药性:对当前及未来治疗方案的临床意义
Top Antivir Med. 2017 Jul/Aug;25(3):103-109.